A110 Efficacy of liposomal bupivacaine versus bupivacaine in port site injections on postoperative pain within enhanced recovery after bariatric surgery (ERABS) program; A Randomized Clinical Trial

MLA

Pearl Ma, et al. “A110 Efficacy of Liposomal Bupivacaine versus Bupivacaine in Port Site Injections on Postoperative Pain within Enhanced Recovery after Bariatric Surgery (ERABS) Program; A Randomized Clinical Trial.” Surgery for Obesity and Related Diseases, vol. 15, Oct. 2019, pp. S5–6. EBSCOhost, https://doi.org/10.1016/j.soard.2019.08.056.

APA

Pearl Ma, Aaron Lloyd, morgan McGrath, Ariel Shuchleib Cung, Ikemefuna Akusoba, Alice Jackson, Daniel Swartz, Keith Boone, & Kelvin Higa. (2019). A110 Efficacy of liposomal bupivacaine versus bupivacaine in port site injections on postoperative pain within enhanced recovery after bariatric surgery (ERABS) program; A Randomized Clinical Trial. Surgery for Obesity and Related Diseases, 15, S5–S6. https://doi.org/10.1016/j.soard.2019.08.056

Chicago

Pearl Ma, Aaron Lloyd, morgan McGrath, Ariel Shuchleib Cung, Ikemefuna Akusoba, Alice Jackson, Daniel Swartz, Keith Boone, and Kelvin Higa. 2019. “A110 Efficacy of Liposomal Bupivacaine versus Bupivacaine in Port Site Injections on Postoperative Pain within Enhanced Recovery after Bariatric Surgery (ERABS) Program; A Randomized Clinical Trial.” Surgery for Obesity and Related Diseases 15 (October): S5–6. doi:10.1016/j.soard.2019.08.056.